Leishmaniose (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Leishmaniose" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

12nih.gov

4^th place

8^th place

11doi.org

2^nd place

4^th place

6sciencedirect.com

149^th place

155^th place

4plos.org

2,112^th place

848^th place

3who.int

195^th place

150^th place

3web.archive.org

1^st place

3scielo.br

1,606^th place

44^th place

2tandfonline.com

507^th place

534^th place

2saude.gov.br

low place

527^th place

1msdmanuals.com

4,047^th place

1,543^rd place

1cdc.gov

218^th place

177^th place

1ijidonline.com

low place

1worldcat.org

5^th place

1wiley.com

222^nd place

196^th place

1elifesciences.org

low place

1cell.com

2,814^th place

1,322^nd place

1intechopen.com

low place

1asm.org

3,555^th place

1,785^th place

1ajtmh.org

low place

ajtmh.org

Mandal, Jharna; et al. (2008). «Short Report: Evaluation of Direct Agglutination Test, rk39 Test, and ELISA for the Diagnosis of Visceral Leishmaniasis» (PDF). The American Society of Tropical Medicine and Hygiene

asm.org

jcm.asm.org

de Ruiter, C. M.; et al. (Setembro de 2014). «Molecular Tools for Diagnosis of Visceral Leishmaniasis: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy». Journal of Clinical Microbiology

cdc.gov

«Neglected Tropical Diseases». cdc.gov. 6 de junho de 2011. Consultado em 28 de novembro de 2014. Cópia arquivada em 4 de dezembro de 2014

cell.com

Alvar, Jorge; Yactayo, Sergio e Bern, Caryn (2006). «Leishmaniasis and poverty». Trends in Parasitology

doi.org

dx.doi.org

Barrett, MP; Croft, SL (2012). «Management of trypanosomiasis and leishmaniasis.». British Medical Bulletin. 104: 175–96. PMC 3530408. PMID 23137768. doi:10.1093/bmb/lds031
GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 de outubro de 2016). «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1545–1602. PMC 5055577. PMID 27733282. doi:10.1016/S0140-6736(16)31678-6
GBD 2015 Mortality and Causes of Death, Collaborators. (8 de outubro de 2016). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1459–1544. PMC 5388903. PMID 27733281. doi:10.1016/s0140-6736(16)31012-1
David M Claborn (2010). «The Biology and Control of Leishmaniasis Vectors». J Glob Infect Dis. 2 (2): 127–134. PMID 20606968. doi:10.4103/0974-777X.62866
Sundar, S; Chakravarty, J (janeiro de 2013). «Leishmaniasis: an update of current pharmacotherapy.». Expert Opinion on Pharmacotherapy. 14 (1): 53–63. PMID 23256501. doi:10.1517/14656566.2013.755515
Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (novembro de 2012). «Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.». The Journal of Antimicrobial Chemotherapy. 67 (11): 2576–97. PMID 22833634. doi:10.1093/jac/dks275
Minodier, P; Parola, P (maio de 2007). «Cutaneous leishmaniasis treatment.». Travel Medicine and Infectious Disease. 5 (3): 150–8. PMID 17448941. doi:10.1016/j.tmaid.2006.09.004
Lozano, R (15 de dezembro de 2012). «Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.». Lancet. 380 (9859): 2095–128. PMID 23245604. doi:10.1016/S0140-6736(12)61728-0
Ejazi, SA; Ali, N (janeiro de 2013). «Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.». Expert Review of Anti-infective Therapy. 11 (1): 79–98. PMID 23428104. doi:10.1586/eri.12.148
Gontijo, Célia Maria Ferreira; Melo, Maria Norma (2004). «Leishmaniose visceral no Brasil: quadro atual, desafios e perspectivas.». Revista Brasileira de Epidemiologia. 7 (3): 338–349. ISSN 1980-5497. doi:10.1590/S1415-790X2004000300011. Consultado em 19 de maio de 2020
Von Stebut, E (março de 2015). «Leishmaniasis.». Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 13 (3): 191–200; quiz 201. PMID 25721626. doi:10.1111/ddg.12595

elifesciences.org

Pigott, David M; et al. (2014). «Global distribution maps of the Leishmaniases». eLife

ijidonline.com

Pavli, Androula Maltezou, Helena C. (2010). «Leishmaniasis as an emerging infection in travelers». International Journal of Infectious Diseases

intechopen.com

Rosa, Luiz H.; et al. (2011). «Endophytic Fungi of Tropical Forests : A Promising Source of Bioactive Prototype Molecules for the Treatment of Neglected Diseases». Drug Development - A Case Study Based Insight into Modern Strategies

msdmanuals.com

Pearson, Richard. «Leishmaniose». Manual Merck. Consultado em 11 de dezembro de 2018

nih.gov

ncbi.nlm.nih.gov

Barrett, MP; Croft, SL (2012). «Management of trypanosomiasis and leishmaniasis.». British Medical Bulletin. 104: 175–96. PMC 3530408. PMID 23137768. doi:10.1093/bmb/lds031
GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 de outubro de 2016). «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1545–1602. PMC 5055577. PMID 27733282. doi:10.1016/S0140-6736(16)31678-6
GBD 2015 Mortality and Causes of Death, Collaborators. (8 de outubro de 2016). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1459–1544. PMC 5388903. PMID 27733281. doi:10.1016/s0140-6736(16)31012-1
David M Claborn (2010). «The Biology and Control of Leishmaniasis Vectors». J Glob Infect Dis. 2 (2): 127–134. PMID 20606968. doi:10.4103/0974-777X.62866
Sundar, S; Chakravarty, J (janeiro de 2013). «Leishmaniasis: an update of current pharmacotherapy.». Expert Opinion on Pharmacotherapy. 14 (1): 53–63. PMID 23256501. doi:10.1517/14656566.2013.755515
Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (novembro de 2012). «Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.». The Journal of Antimicrobial Chemotherapy. 67 (11): 2576–97. PMID 22833634. doi:10.1093/jac/dks275
Minodier, P; Parola, P (maio de 2007). «Cutaneous leishmaniasis treatment.». Travel Medicine and Infectious Disease. 5 (3): 150–8. PMID 17448941. doi:10.1016/j.tmaid.2006.09.004
Lozano, R (15 de dezembro de 2012). «Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.». Lancet. 380 (9859): 2095–128. PMID 23245604. doi:10.1016/S0140-6736(12)61728-0
Ejazi, SA; Ali, N (janeiro de 2013). «Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.». Expert Review of Anti-infective Therapy. 11 (1): 79–98. PMID 23428104. doi:10.1586/eri.12.148
Werneck, Guilherme Loureiro (Junho de 2014). «Visceral leishmaniasis in Brazil: rationale and concerns related to reservoir control». Revista de Saude Publica
Steverding, Dietmar (2017). «The history of leishmaniasis». Parasites and Vectors
Von Stebut, E (março de 2015). «Leishmaniasis.». Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 13 (3): 191–200; quiz 201. PMID 25721626. doi:10.1111/ddg.12595

plos.org

journals.plos.org

Alvar, Jorge; et al. (Maio de 2012). «Leishmaniasis worldwide and global estimates of its incidence». PLoS One
Melo, Helen Aline Rossoni, Diogo Francisco Teodoro, Ueslei (2017). «Spatial distribution of cutaneous leishmaniasis in the state of Paraná, Brazil». PLoS One
Bezerra, Juliana Maria Trindade; et al. (setembro de 2018). «Burden of leishmaniasis in Brazil and federated units, 1990-2016: Findings from Global Burden of Disease Study 2016». PLOS Neglected Tropical Diseases
Du, Rebecca; et al. (Maio de 2016). «Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa». PLoS Neglected Tropical Diseases

saude.gov.br

portalarquivos.saude.gov.br

Ministério da Saúde (2016). «Guia de vigilância em saúde - pg. 504-542» (PDF). Brasília - DF

bvsms.saude.gov.br

Ministério da Saúde (2006). «Manual de Vigilância e Controle da Leishmaniose Visceral» (PDF). Secretaria de Vigilância em Saúde Departamento de Vigilância Epidemiológica

scielo.br

Gontijo, Célia Maria Ferreira; Melo, Maria Norma (2004). «Leishmaniose visceral no Brasil: quadro atual, desafios e perspectivas.». Revista Brasileira de Epidemiologia. 7 (3): 338–349. ISSN 1980-5497. doi:10.1590/S1415-790X2004000300011. Consultado em 19 de maio de 2020
dos Reis, Lisiane Lappe; et al. (2017). «Changes in the epidemiology of visceral leishmaniasis in Brazil from 2001 to 2014». Revista da Sociedade Brasileira de Medicina Tropical
Antonio, Liliane de Fátima; et al. (Outubro de 2014). «Montenegro skin test and age of skin lesion as predictors of treatment failure in cutaneous leishmaniasis». Revista do Instituto de Medicina Tropical de Sao Paulo

sciencedirect.com

Michel, Grégory; et al. (Junho de 2011). «Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human». Acta Tropica
Kevric, Ines Cappel, Mark A. Keeling, James H. (2015). «New World and Old World Leishmania Infections A Practical Review». Dermatologic Clinics
Reithinger, Richard; et al. (Setembro de 2007). «Cutaneous Leishmaniasis». The Lancet Infectious Diseases
Oryan, A. Akbari, M. (2016). «Worldwide risk factors in leishmaniasis». Asian Pacific Journal of Tropical Medicine
Guerin, Philippe J; et al. (Agosto de 2002). «Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda». The Lancet. Infectious diseases
Herwaldt, Barbara L (Outubro de 1999). «Leishmaniasis». The Lancet

tandfonline.com

Hiro Goto & José Angelo Lauletta Lindoso (2010). «Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis». Expert Review of Anti-infective Therapy ISSN:
Sarfaraz Ahmad Ejazi e Nahid Ali (2013). «Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects». Expert Review of Anti-infective Therapy

web.archive.org

«Leishmaniasis Fact sheet N°375». World Health Organization. Janeiro de 2014. Consultado em 17 de fevereiro de 2014. Cópia arquivada em 21 de fevereiro de 2014
«Leishmaniasis Magnitude of the problem». World Health Organization. Consultado em 17 de fevereiro de 2014. Cópia arquivada em 26 de outubro de 2013
«Neglected Tropical Diseases». cdc.gov. 6 de junho de 2011. Consultado em 28 de novembro de 2014. Cópia arquivada em 4 de dezembro de 2014

who.int

«Leishmaniasis Fact sheet N°375». World Health Organization. Janeiro de 2014. Consultado em 17 de fevereiro de 2014. Cópia arquivada em 21 de fevereiro de 2014
«Leishmaniasis Magnitude of the problem». World Health Organization. Consultado em 17 de fevereiro de 2014. Cópia arquivada em 26 de outubro de 2013
WHO. World Health Organization (2016). «WHO: Weekly epidemiological record» (PDF). Weekly Epidemiological Record

wiley.com

onlinelibrary.wiley.com

Singh, Sarman Sharma, Umakant Mishra, Jyotsna (2011). «Post-kala-azar dermal leishmaniasis: Recent developments». International Journal of Dermatology

worldcat.org

Gontijo, Célia Maria Ferreira; Melo, Maria Norma (2004). «Leishmaniose visceral no Brasil: quadro atual, desafios e perspectivas.». Revista Brasileira de Epidemiologia. 7 (3): 338–349. ISSN 1980-5497. doi:10.1590/S1415-790X2004000300011. Consultado em 19 de maio de 2020